Months After Last Dose1− Rapid Reductions in Proteinuria and Serum Gd-IgA1 Levels Were Sustained Through Week 961 No Serious Adverse Events or Opportunistic Infections Were Observed Through Week 961 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback